← Trulieve Cannabis Corp.
| Annual Trend | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|
| (Gain) loss from disposal of discontinued operations | — | — | $0 | $49.1m | $69.5m | $0 | ($826k) | |
| Cash and cash equivalents of discontinued operations, beginning of period | $91.8m | $146.7m | $233.7m | $621k | $301k | $0 | $0 | |
| Depreciation and amortization | $5.1m | $12.6m | $48.1m | $121.8m | $110.8m | $112.8m | $117.6m | |
| Depreciation included in cost of goods sold | — | — | $24.1m | $52.5m | $59.8m | $53.6m | $55.8m | |
| Deferred income taxes | — | — | — | ($27.2m) | ($17.2m) | ($10.4m) | ($18.6m) | |
| Impairment and other charges, net of (recoveries) | — | — | — | — | $6.7m | ($5.3m) | $4.8m | |
| Impairment of goodwill | — | — | $0 | $0 | $307.6m | $0 | $0 | |
| Share-based compensation | — | $2.8m | $9.3m | $18.1m | $10.6m | $20.2m | $20.5m | |
| Loss (gain) on debt extinguishments, net | — | — | $0 | $0 | ($5.9m) | $0 | $1.7m | |
| Net loss | $53.1m | $63.0m | $17.4m | ($252.7m) | ($533.1m) | ($160.6m) | ($122.2m) | |
| Other non-cash changes | — | — | — | $3.7m | $6.5m | $943k | $20.1m | |
| Inventories | ($54.5m) | ($22.5m) | ($19.6m) | ($83.4m) | $83.3m | ($18.7m) | ($10.9m) | |
| Accounts receivable | — | $1.1m | ($4.9m) | ($4.2m) | ($1.7m) | $741k | ($3.7m) | |
| Other assets | $147k | ($9.7m) | ($6.3m) | $2.4m | $3.0m | ($2.9m) | $5.8m | |
| Accounts payable and accrued liabilities | $13.6m | $298k | ($9.7m) | ($819k) | $1.6m | $7.2m | ($11.3m) | |
| Income tax receivable / payable | ($6.7m) | ($2.5m) | ($13.0m) | $19.8m | ($48.8m) | ($8.5m) | $1.6m | |
| Other liabilities | — | $704k | ($15.8m) | ($1.4m) | ($13.3m) | $1.9m | ($16.4m) | |
| Uncertain tax position liabilities | — | — | $2.8m | $12.8m | $160.9m | $264.9m | $223.2m | |
| Proceeds received from insurance for operating expenses | — | — | — | $0 | $0 | $8.0m | $5.7m | |
| Purchases of property and equipment | ($71.8m) | ($99.9m) | ($275.9m) | ($164.7m) | ($40.4m) | ($121.5m) | ($44.2m) | |
| Purchases of internal use software | — | — | ($3.7m) | ($9.2m) | ($10.6m) | ($25.1m) | ($16.3m) | |
| Other purchase and payments | — | — | — | — | ($5.4m) | ($7.6m) | ($117k) | |
| Other proceeds | — | — | — | — | $24.7m | $3.2m | $0 | |
| Proceeds from private placement notes | — | — | $6.0m | $75.6m | $0 | $0 | $140.0m | |
| Payments on long-term borrowings | — | — | — | — | ($191.4m) | ($8.1m) | ($393.3m) | |
| Payments for taxes related to net share settlement of equity awards | — | — | ($1.1m) | ($615k) | ($466k) | ($14.8m) | ($4.8m) | |
| Other payments and distributions | — | — | — | — | ($8.4m) | ($13.8m) | ($9.0m) | |
| Interest | $7.4m | $22.1m | $39.1m | $76.1m | $81.2m | $65.4m | $70.3m | |
| ASC 842 lease additions - operating and finance leases | $42.3m | $33.6m | $61.2m | $41.1m | $14.3m | $51.5m | $17.3m | |
| Purchases of property and equipment in accounts payable and accrued liabilities | — | — | $17.9m | $3.9m | $2.8m | $5.3m | $3.7m | |
| Reclassification of assets to held for sale | — | — | $0 | $0 | $18.4m | $10.6m | $5.7m | |
| Operating license intangible placed into service, transfer from other assets | — | — | — | — | $0 | $0 | $6.5m | |
| Redeemed non-controlling interest, former mezzanine equity | — | — | — | $0 | $0 | $2.6m | $0 | |
| Redemptions of non-controlling interest | — | — | — | $0 | $0 | $2.1m | $0 | |
| Noncash partial extinguishment of construction finance liability | — | — | $0 | $0 | $18.5m | $0 | $0 | |
| Net cash provided by operating activities | $19.1m | $99.6m | $12.9m | $23.1m | $201.8m | $271.5m | $272.8m | |
| Purchases of short-term investments | — | — | — | $0 | $0 | ($80.0m) | $0 | |
| Maturities of short-term investments | — | — | — | $0 | $0 | $20.0m | $60.0m | |
| Net cash provided by (used in) investing activities | ($94.7m) | ($174.7m) | ($215.2m) | ($215.1m) | ($37.5m) | ($206.6m) | $13.5m | |
| Payments for debt issuance costs | — | — | ($251k) | ($832k) | ($774k) | $0 | ($3.3m) | |
| Net cash used in financing activities | $143.0m | $129.9m | $289.2m | $177.8m | ($175.6m) | ($33.4m) | ($270.5m) | |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | $67.4m | $54.9m | $86.9m | ($14.2m) | ($11.2m) | $31.4m | $15.8m | |
| Cash, cash equivalents, and restricted cash, beginning of period | — | $146.7m | $233.1m | $218.9m | $208.0m | $239.7m | $255.5m | |
| Cash and cash equivalents, beginning balance | — | $146.7m | $230.1m | $212.3m | $201.4m | $238.8m | $255.5m | |
| Restricted cash | — | — | — | — | $6.6m | $907k | $0 | |
| Income taxes paid, net of (refunds) | — | — | $178.7m | $146.7m | $52.6m | ($48.4m) | $1.5m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.